Malaria Treatment Shows Potential in Animal, Cell Models of Sjögren’s
The anti-malaria medication artesunate could be a potential treatment of Sjögren’s syndrome, a study suggested. In mouse and cellular models, artesunate showed an ability to inhibit inflammatory T-helper 17 (Th17) cells and ease Sjögren’s symptoms. The study, “Artesunate suppresses Th17 response via inhibiting IRF4- mediated glycolysis…